Eph receptors as therapeutic targets in glioblastoma

Por Day, B W, Stringer, B W, Boyd, A W
Publicado em 2014

P01.07 The Dystroglycan Complex Promotes Mesenchymal-Like Glioblastoma through Interaction with EphA Receptor Tyrosine Kinases

Por Day, B. W., Al-Ejeh, F., Bruce, Z. C., Ensbey, K. S., Robertson, T., Stringer, B. W., Rich, J. N., Lathia, J. D., Campbell, K. P., Boyd, A. W.
Publicado no Neuro Oncol (2017)

Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma

Por Greenall, S A, Lim, Y C, Mitchell, C B, Ensbey, K S, Stringer, B W, Wilding, A L, O'Neill, G M, McDonald, K L, Gough, D J, Day, B W, Johns, T G
Publicado no Oncogenesis (2017)

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant

Por Zakaria, Z, Tivnan, A, Flanagan, L, Murray, D W, Salvucci, M, Stringer, B W, Day, B W, Boyd, A W, Kögel, D, Rehm, M, O'Brien, D F, Byrne, A T, Prehn, J H M
Publicado no Br J Cancer (2016)